TrialLeukemia2014

Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients.

U Platzbecker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.